Wanhua BorsodChem sales rise but miss target

Pharma

Sales and output of Hungary's Wanhua BorsodChem rose last year, but the Chinese-owned chemicals company "failed to achieve the original targets", CEO Jiansheng Ding said in Monday's issue of daily Népszabadság.

Ding said the company was trying to use synergy within the group to meet the challenge of the economic crisis. He added that Chinese owner Wanhua had spent €320 million to complete BorsodChem's TDI-2 plant, improve technology at its MDI plant and give the company liquidity. 

Ding said that if the Hungarian government could improve the investment environment, other Chinese companies could follow Wanhua's example of success.

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.

Support the BBJ

Industry